Owing to its huge, aged population base, Asia accounts for over 55% of the estimated global incidence of Acute pancreatitis, with China, Japan, and India collectively contributing to over a quarter of the cases.
一家致力於推進新藥開發進程的國際性受託研究機構 (CRO) 和科學諮詢合作夥伴
立足臨床試驗,護航人類健康未來。
協同合作共進,科創驅動前行。
深耕產業標竿,鑄就卓越口碑。
深耕臨床科研數十載,引領產業發展標竿。
Owing to its huge, aged population base, Asia accounts for over 55% of the estimated global incidence of Acute pancreatitis, with China, Japan, and India collectively contributing to over a quarter of the cases.